排序方式： 共有24条查询结果，搜索用时 0 毫秒
1.
Roth JA Hibbard B Frank DE Kesl L Robb EJ 《Veterinary therapeutics : research in applied veterinary medicine》2002,3(3):347-353
Holstein steer calves received a single injection of Miglyol (Sasol Chemical Industries, Ltd.) subcutaneously as a placebo, dihydroheptaprenol (DHP) (4 mg/kg) emulsified with lecithin subcutaneously, DHP in solution in Miglyol (4 mg/kg) subcutaneously, or DHP in solution in Miglyol (4 mg/kg) intranasally. The DHP emulsified in lecithin emulsion administered subcutaneously caused a substantial increase in body temperature, total leukocyte count, total neutrophil count, neutrophil cytochrome-c reduction, and neutrophil iodination 24 hours after administration and, for some of the parameters, at 48 hours. The DHP formulation in Miglyol did not have any of these effects when administered subcutaneously or intranasally. The carrier and formulation of DHP apparently have major effects on the biologic activity of DHP. 相似文献
2.
3.
Hibbard B Robb EJ Chester ST Dame KJ Moseley WW Bryson WL 《Veterinary therapeutics : research in applied veterinary medicine》2002,3(1):22-30
Three studies were conducted to determine and confirm the effective dosage rate of ceftiofur crystalline-free acid sterile suspension (CCFA-SS, 200 mg ceftiofur equivalents [CE]/ml), a long-acting ceftiofur formulation, for control and treatment of bovine respiratory disease (BRD). In each study, CCFA-SS was administered once by subcutaneous (SC) injection in the middle third of the posterior aspect of the ear. Study 1 was conducted using an intratracheal challenge with Mannheimia (formerly Pasteurella) haemolytica and dosages ranging from 0 to 8.8 mg CE/kg to select a dosage for further field testing. In Study 2, a single dose of CCFA-SS at 0.0, 4.4, or 6.6 mg CE/kg was administered when uniform clinical signs of BRD were present in feedlot cattle. Study 3 was conducted in several feedlots to evaluate the efficacy, practicality, and safety of CCFA-SS at 4.4 or 6.6 mg CE/kg compared with a placebo control or tilmicosin for preemptive control of BRD. In Study 1, the effective dose was determined to be 5.35 mg CE/kg; therefore, 4.4 and 6.6 mg CE/kg were selected as the dosages for further field testing. Administration of CCFA-SS at 4.4 or 6.6 mg CE/kg improved treatment success compared with negative controls (P < or =.05 for both doses) in Study 2. In Study 3, a single administration of 4.4 or 6.6 mg CE/kg was comparable to tilmicosin (P <.001) and was significantly better than placebo (P <.001) for the control of BRD. Using the ear as an administration site was acceptable under field conditions and was well tolerated by all animals. These studies demonstrated that a single administration of CCFA-SS by SC injection in the middle third of the posterior aspect of the ear at 4.4 or 6.6 mg CE/kg is effective, safe, and practical for preemptive control and treatment of the bacterial component of BRD in feedlot cattle. Administration in an inedible tissue results in a short withdrawal time and no injection-site trimming at slaughter. 相似文献
4.
5.
6.
7.
8.
Combined optical and radio images of galaxies can provide new insights into the sizes, masses, and possible evolution of these objects. Deep optical and neutral hydrogen images of Markarian 348, a type 2 Seyfert galaxy, show that it is a gigantic spiral (perhaps the largest known non-cluster galaxy). Measurements of the neutral hydrogen velocity field and spiral structure, and detection of an optical "tidal plume," all provide evidence that it has been subject to tidal disruption. The measured velocities yield a mass-to-light ratio for this object (within a radius of 130 kiloparsecs from its nucleus) that is similar to the ratio found for the inner regions of most galaxies of similar type. This is one of the few cases where detailed velocity measurements have demonstrated that a galaxy with an active nucleus has been subject to extensive tidal perturbation. 相似文献
9.
10.
